Collaboration with longevity biotech firm Aria Bioscience to translate the technology into consumer healthcare products A new orally taken, gut-based compound developed by scientists from NTU Singapore, reduces the amount of dietary fat absorbed in the intestines. This differs from most existing weight-loss drugs, which act mainly by suppressing appetite or altering glucose regulation, as well as supplements that claim to boost metabolism to burn more calories. The new techno

Diet plays a central role in skin health. Not only does it influence the appearance of your skin, but it also helps stimulate the...

At ARIA Bioscience , we believe longevity isn’t about defying age — it’s about redefining how we experience it . Backed by clinical...